The molecular landscape of CNL is dominated by CSF3R mutations, which are found in the majority of CNL cases (64% to 100%) (Table 1) [16,17,18,19,20,21,22], first described in 2013 [23]. This evidence concerns the gene CSF3R and chronic neutrophilic leukemia.